Do you need to have EGFR for car T treatment

Let me clarify what CAR-T treatment is and how EGFR relates to it.

What is CAR-T Treatment?

CAR-T is a type of immunotherapy that works very differently from targeted therapy. Here's how:

• CAR-T stands for: Chimeric Antigen Receptor T-cell therapy
• How it works: Doctors remove your own immune cells (T cells), modify them in a lab to recognize and attack cancer cells, then put them back into your body
• Target: CAR-T cells are designed to recognize specific proteins on cancer cell surfaces—not genetic mutations like EGFR

EGFR and CAR-T: Different Approaches

EGFR mutations (changes in a gene that makes a growth receptor) are typically treated with:

• Targeted therapy (like kinase inhibitors or antibody therapy) that blocks the overactive EGFR protein
• These are pills or infusions designed specifically for EGFR-mutated cancers

CAR-T therapy targets different proteins on cancer cells, such as:

• CD19 (mainly used in blood cancers like lymphoma and leukemia)
• Other surface proteins being studied in clinical trials

Important Context

According to NCCN Guidelines, CAR-T is currently FDA-approved primarily for certain blood cancers. Researchers are studying CAR-T for solid tumors (like lung cancer), but this is still emerging research.

Questions to ask your oncologist:

1. Is CAR-T an appropriate option for my specific cancer type?
2. What proteins on my cancer cells would CAR-T target?
3. Are there clinical trials for CAR-T that match my diagnosis?
4. Would targeted therapy (if I have EGFR mutations) or immunotherapy be better options for me?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.